Featured Products
Our Promise to You
Guaranteed product quality, expert customer support
ONLINE INQUIRY
HeLa 382
Cat.No.: CSC-6261W
Species: Homo sapiens, human
Source: cervix
Morphology: continuous culture, grown as monolayer, morphology epithelial-like
Culture Properties: Monolayer
- Specification
- Q & A
- Customer Review
Ethical considerations include patient consent for CTC analysis, privacy and data security, and equitable access to CTC-based diagnostics and therapies.
Ask a Question
Average Rating: 4.0 | 1 Scientist has reviewed this product
Exceptional products
We found these cell biology products to be instrumental in optimizing our cellular applications, delivering high-quality cell cultures, and supporting the precise execution of our experiments.
02 May 2023
Ease of use
After sales services
Value for money
Write your own review
- You May Also Need
Description: The HeLa 422 cell line is a subclone of the cell line HeLa. The original HeLa cell line was derived from a cervical carcinoma from a 31 year old female and the HeLa 422 cell line was transfected with ER-pBact, human estrogen receptor cDNA, under control of the human beta actin promotor, resistant to G418S.;
Description: Transfected with the exon 4 defective variant of ER-pBact cDNA, human estrogen receptor cDNA, under control of the human beta actin promotor, resistant to G418S.
Species: human, Black female 31 years old
Tissue: cervix
Tumor: carcinoma, epitheloid
Original line: HeLa
Description: These cells were cloned from the GIRARDI HEART cell line (passage #623) in 1981 and were thought to "represent human heart cells"; however, isoenzyme analysis (Nelson-Rees et al., Science 191: 96-97, 1976) and DNA fingerprinting at the Creative Bioarray established unequivocally that this cell line must be considered de facto a subclone of HELA; cells were described to be sensitive to various toxins and hormones
Description: These cells were cloned from the GIRARDI HEART cell line (passage #623) in 1981 and were thought to "represent human heart cells"; however, isoenzyme analysis (Nelson-Rees et al., Science 191: 96-97, 1976) and DNA fingerprinting at the Creative Bioarray established unequivocally that this cell line must be considered de facto a subclone of HELA; cells were described to be sensitive to various toxins and hormones
Description: Established from the ascitic fluid of a 69-year-old Caucasian woman with endometrial carcinoma in relapse in 1985
